Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 1999, p. 406-409, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Detection of gyrA Mutations among 335 Pseudomonas aeruginosa Strains Isolated in Japan and Their
Susceptibilities to Fluoroquinolones
Takashi
Takenouchi,1,*
Eiko
Sakagawa,1 and
Mie
Sugawara2
Biological Research
Laboratories1 and
Biomedical Research
Laboratories,2 Sankyo Co., Ltd., 2-58 Hiromachi 1-chome, Shinagawa-ku, Tokyo 140-8710, Japan
Received 6 July 1998/Returned for modification 3 September
1998/Accepted 12 November 1998
gyrA point mutations in 335 clinical Pseudomonas
aeruginosa isolates were examined mainly by nonisotopic
single-strand conformation polymorphism analysis and direct sequencing.
Seven types of missense gyrA mutations were
observed in 70 of 335 strains (20.9%), and ciprofloxacin MICs were
3.13 µg/ml for 63 of 70 strains (90.0%). These included two double
point mutations and three novel mutations (Ala-67
Ser plus
Asp-87
Gly, Ala-84
Pro, and Gln-106
Leu). Thr-83
Ile mutants
were predominantly observed (63 of 70 mutants) and showed high-level fluoroquinolone resistance (ciprofloxacin MIC at which 50%
of isolates are inhibited, 25 µg/ml).
*
Corresponding author. Mailing address: Biological
Research Laboratories, Sankyo Co., Ltd., 2-58 Hiromachi 1-chome,
Shinagawa-ku, Tokyo 140-8710, Japan. Phone: 81-3-3492-3131. Fax:
81-3-5436-8566. E-mail: takeno{at}shina.sankyo.co.jp.
Antimicrobial Agents and Chemotherapy, February 1999, p. 406-409, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lister, P. D., Wolter, D. J., Hanson, N. D.
(2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev.
22: 582-610
[Abstract]
[Full Text]
-
Han, X. Y., Andrade, R. A.
(2005). Brevundimonas diminuta infections and its resistance to fluoroquinolones. J Antimicrob Chemother
55: 853-859
[Abstract]
[Full Text]
-
Kugelberg, E., Lofmark, S., Wretlind, B., Andersson, D. I.
(2005). Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J Antimicrob Chemother
55: 22-30
[Abstract]
[Full Text]
-
Lomholt, J A, Kilian, M
(2003). Ciprofloxacin susceptibility of Pseudomonas aeruginosa isolates from keratitis. Br J Ophthalmol
87: 1238-1240
[Abstract]
[Full Text]
-
Fluit, A. C., Visser, M. R., Schmitz, F.-J.
(2001). Molecular Detection of Antimicrobial Resistance. Clin. Microbiol. Rev.
14: 836-871
[Abstract]
[Full Text]
-
Lindler, L. E., Fan, W., Jahan, N.
(2001). Detection of Ciprofloxacin-Resistant Yersinia pestis by Fluorogenic PCR Using the LightCycler. J. Clin. Microbiol.
39: 3649-3655
[Abstract]
[Full Text]
-
Akasaka, T., Tanaka, M., Yamaguchi, A., Sato, K.
(2001). Type II Topoisomerase Mutations in Fluoroquinolone-Resistant Clinical Strains of Pseudomonas aeruginosa Isolated in 1998 and 1999: Role of Target Enzyme in Mechanism of Fluoroquinolone Resistance. Antimicrob. Agents Chemother.
45: 2263-2268
[Abstract]
[Full Text]
-
Loeffler, J., Hagmeyer, L., Hebart, H., Henke, N., Schumacher, U., Einsele, H.
(2000). Rapid Detection of Point Mutations by Fluorescence Resonance Energy Transfer and Probe Melting Curves in Candida Species. Clin. Chem.
46: 631-635
[Abstract]
[Full Text]